WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) II L.P. reported 1 transaction at METSERA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/3/2025ACC: 0000950170-25-012574
→
10% Owner
Since Jan 2025
-2.51M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.86M acquired · 4.37M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.86M
Price / share
—
Trade value
—
% of position
New position
1/30/2025
0.00→1.86M
Total
Net shares
+1.86M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2025 | C · Conversion | +1.86M | — | — | New position | 0.00 | 1.86M |
| Total | +1.86M | $0.00 | ||||||
Derivative Transactions1
Series B Preferred Stock
Direct
Converts to
Common Stock
1.86M shares
Shares
−4.37M
Strike price
Held after
0.00
Exercisable
—
1/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock1.86M shares | 1/30/2025 | C · Conversion | −4.37M | — | 0.00 |